BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37710176)

  • 1. Quercetin inhibits the metabolism of arachidonic acid by inhibiting the activity of CYP3A4, thereby inhibiting the progression of breast cancer.
    Tang H; Kuang Y; Wu W; Peng B; Fu Q
    Mol Med; 2023 Sep; 29(1):127. PubMed ID: 37710176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP3A4 mediates growth of estrogen receptor-positive breast cancer cells in part by inducing nuclear translocation of phospho-Stat3 through biosynthesis of (±)-14,15-epoxyeicosatrienoic acid (EET).
    Mitra R; Guo Z; Milani M; Mesaros C; Rodriguez M; Nguyen J; Luo X; Clarke D; Lamba J; Schuetz E; Donner DB; Puli N; Falck JR; Capdevila J; Gupta K; Blair IA; Potter DA
    J Biol Chem; 2011 May; 286(20):17543-59. PubMed ID: 21402692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the content differences of arachidonic acid metabolites in a mouse model of breast cancer by using LC-MS/MS.
    Chen A; Zhang Y; Sun D; Xu Y; Guo Y; Wang X
    J Pharm Biomed Anal; 2021 Feb; 194():113763. PubMed ID: 33279296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Breast Cancer Potential of Quercetin via the Akt/AMPK/Mammalian Target of Rapamycin (mTOR) Signaling Cascade.
    Rivera Rivera A; Castillo-Pichardo L; Gerena Y; Dharmawardhane S
    PLoS One; 2016; 11(6):e0157251. PubMed ID: 27285995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heme Binding Biguanides Target Cytochrome P450-Dependent Cancer Cell Mitochondria.
    Guo Z; Sevrioukova IF; Denisov IG; Zhang X; Chiu TL; Thomas DG; Hanse EA; Cuellar RAD; Grinkova YV; Langenfeld VW; Swedien DS; Stamschror JD; Alvarez J; Luna F; Galván A; Bae YK; Wulfkuhle JD; Gallagher RI; Petricoin EF; Norris B; Flory CM; Schumacher RJ; O'Sullivan MG; Cao Q; Chu H; Lipscomb JD; Atkins WM; Gupta K; Kelekar A; Blair IA; Capdevila JH; Falck JR; Sligar SG; Poulos TL; Georg GI; Ambrose E; Potter DA
    Cell Chem Biol; 2017 Oct; 24(10):1259-1275.e6. PubMed ID: 28919040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction.
    Jia L; Huang S; Yin X; Zan Y; Guo Y; Han L
    Life Sci; 2018 Sep; 208():123-130. PubMed ID: 30025823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic and free radical formation of cis- and trans- epoxyeicosatrienoic acids in vitro and in vivo.
    Aliwarga T; Raccor BS; Lemaitre RN; Sotoodehnia N; Gharib SA; Xu L; Totah RA
    Free Radic Biol Med; 2017 Nov; 112():131-140. PubMed ID: 28734877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P16 promotes the growth and mobility potential of breast cancer both in vitro and in vivo: the key role of the activation of IL-6/JAK2/STAT3 signaling.
    Wang L; Zhan X; Shen X; Li M; Yang J; Yu W; Chen H; Jin B; Mao Z
    Mol Cell Biochem; 2018 Sep; 446(1-2):137-148. PubMed ID: 29388151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quercetin Inhibits Cell Migration and Invasion in Human Osteosarcoma Cells.
    Lan H; Hong W; Fan P; Qian D; Zhu J; Bai B
    Cell Physiol Biochem; 2017; 43(2):553-567. PubMed ID: 28965117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quercetin exerts anti-melanoma activities and inhibits STAT3 signaling.
    Cao HH; Tse AK; Kwan HY; Yu H; Cheng CY; Su T; Fong WF; Yu ZL
    Biochem Pharmacol; 2014 Feb; 87(3):424-34. PubMed ID: 24275163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated 14,15- epoxyeicosatrienoic acid by increasing of cytochrome P450 2C8, 2C9 and 2J2 and decreasing of soluble epoxide hydrolase associated with aggressiveness of human breast cancer.
    Wei X; Zhang D; Dou X; Niu N; Huang W; Bai J; Zhang G
    BMC Cancer; 2014 Nov; 14():841. PubMed ID: 25406731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arachidonic acid metabolism in the marine fish Stenotomus chrysops (Scup) and the effects of cytochrome P450 1A inducers.
    Schlezinger JJ; Parker C; Zeldin DC; Stegeman JJ
    Arch Biochem Biophys; 1998 May; 353(2):265-75. PubMed ID: 9606961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPARα ligand, AVE8134, and cyclooxygenase inhibitor therapy synergistically suppress lung cancer growth and metastasis.
    Wu L; Wang W; Dai M; Li H; Chen C; Wang D
    BMC Cancer; 2019 Dec; 19(1):1166. PubMed ID: 31791289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quercetin Inhibits Glioblastoma Growth and Prolongs Survival Rate through Inhibiting Glycolytic Metabolism.
    Wang L; Ji S; Liu Z; Zhao J
    Chemotherapy; 2022; 67(3):132-141. PubMed ID: 35249013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiology.
    Sacerdoti D; Gatta A; McGiff JC
    Prostaglandins Other Lipid Mediat; 2003 Oct; 72(1-2):51-71. PubMed ID: 14626496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioactivation of arachidonic acid by the cytochrome P450 monooxygenases of guinea pig lung: the orthologue of cytochrome P450 2B4 is solely responsible for formation of epoxyeicosatrienoic acids.
    Knickle LC; Bend JR
    Mol Pharmacol; 1994 Jun; 45(6):1273-80. PubMed ID: 8022420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNA hsa_circ_0043278 inhibits breast cancer progression via the miR-455-3p/EI24 signalling pathway.
    Shi Y; Liu C
    BMC Cancer; 2021 Nov; 21(1):1249. PubMed ID: 34800978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p.
    Zang H; Li Y; Zhang X; Huang G
    Thorac Cancer; 2020 Jul; 11(7):1891-1903. PubMed ID: 32445273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circ_0008039 supports breast cancer cell proliferation, migration, invasion, and glycolysis by regulating the miR-140-3p/SKA2 axis.
    Dou D; Ren X; Han M; Xu X; Ge X; Gu Y; Wang X; Zhao S
    Mol Oncol; 2021 Feb; 15(2):697-709. PubMed ID: 33244865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2.
    Liang WH; Li N; Yuan ZQ; Qian XL; Wang ZH
    Mol Carcinog; 2019 Apr; 58(4):461-473. PubMed ID: 30457164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.